Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Similar articles for PubMed (Select 20158473)

1.

Epoxyeicosatrienoic acid analogs and vascular function.

Sudhahar V, Shaw S, Imig JD.

Curr Med Chem. 2010;17(12):1181-90. Review.

2.

Epoxides and soluble epoxide hydrolase in cardiovascular physiology.

Imig JD.

Physiol Rev. 2012 Jan;92(1):101-30. doi: 10.1152/physrev.00021.2011. Review.

3.

Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease.

Elmarakby AA.

Am J Physiol Regul Integr Comp Physiol. 2012 Feb 1;302(3):R321-30. doi: 10.1152/ajpregu.00606.2011. Epub 2011 Nov 23. Review.

4.

Vascular pharmacology of epoxyeicosatrienoic acids.

Pfister SL, Gauthier KM, Campbell WB.

Adv Pharmacol. 2010;60:27-59. doi: 10.1016/B978-0-12-385061-4.00002-7. Review.

5.

Targeting epoxides for organ damage in hypertension.

Imig JD.

J Cardiovasc Pharmacol. 2010 Oct;56(4):329-35. doi: 10.1097/FJC.0b013e3181e96e0c. Review.

6.

Inside epoxyeicosatrienoic acids and cardiovascular disease.

Tacconelli S, Patrignani P.

Front Pharmacol. 2014 Nov 10;5:239. doi: 10.3389/fphar.2014.00239. eCollection 2014. Review.

7.

The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.

Xu X, Zhang XA, Wang DW.

Adv Drug Deliv Rev. 2011 Jul 18;63(8):597-609. doi: 10.1016/j.addr.2011.03.006. Epub 2011 Apr 6. Review.

PMID:
21477627
8.

Emerging role of epoxyeicosatrienoic acids in coronary vascular function.

Larsen BT, Gutterman DD, Hatoum OA.

Eur J Clin Invest. 2006 May;36(5):293-300. Review.

PMID:
16634832
9.

14,15-EET analogs: characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries.

Gauthier KM, Falck JR, Reddy LM, Campbell WB.

Pharmacol Res. 2004 Jun;49(6):515-24.

PMID:
15026029
10.

Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.

Shahabi P, Siest G, Visvikis-siest S.

Drug Metab Rev. 2014 Feb;46(1):33-56. doi: 10.3109/03602532.2013.837916. Epub 2013 Sep 16. Review.

PMID:
24040964
11.

Development of epoxyeicosatrienoic acid analogs with in vivo anti-hypertensive actions.

Imig JD, Elmarakby A, Nithipatikom K, Wei S, Capdevila JH, Tuniki VR, Sangras B, Anjaiah S, Manthati VL, Sudarshan Reddy D, Falck JR.

Front Physiol. 2010 Dec 3;1:157. doi: 10.3389/fphys.2010.00157. eCollection 2010.

12.

Epoxyeicosatrienoic acids: formation, metabolism and potential role in tissue physiology and pathophysiology.

Kaspera R, Totah RA.

Expert Opin Drug Metab Toxicol. 2009 Jul;5(7):757-71. doi: 10.1517/17425250902932923. Review.

PMID:
19505190
13.

Arachidonic acid cytochrome P450 epoxygenase pathway.

Spector AA.

J Lipid Res. 2009 Apr;50 Suppl:S52-6. doi: 10.1194/jlr.R800038-JLR200. Epub 2008 Oct 23. Review.

14.

Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids.

Spiecker M, Liao JK.

Arch Biochem Biophys. 2005 Jan 15;433(2):413-20. Review.

PMID:
15581597
15.

14,15-Dihydroxy-eicosa-5(Z)-enoic acid selectively inhibits 14,15-epoxyeicosatrienoic acid-induced relaxations in bovine coronary arteries.

Bukhari IA, Gauthier KM, Jagadeesh SG, Sangras B, Falck JR, Campbell WB.

J Pharmacol Exp Ther. 2011 Jan;336(1):47-55. doi: 10.1124/jpet.110.169797. Epub 2010 Sep 29.

16.

Roles of epoxyeicosatrienoic acids in vascular regulation and cardiac preconditioning.

Gauthier KM, Yang W, Gross GJ, Campbell WB.

J Cardiovasc Pharmacol. 2007 Dec;50(6):601-8. Review.

PMID:
18091575
17.

Epoxyeicosatrienoic acids function as selective, endogenous antagonists of native thromboxane receptors: identification of a novel mechanism of vasodilation.

Behm DJ, Ogbonna A, Wu C, Burns-Kurtis CL, Douglas SA.

J Pharmacol Exp Ther. 2009 Jan;328(1):231-9. doi: 10.1124/jpet.108.145102. Epub 2008 Oct 3.

18.

Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation.

Oltman CL, Weintraub NL, VanRollins M, Dellsperger KC.

Circ Res. 1998 Nov 2;83(9):932-9.

19.

Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function.

Imig JD.

Prostaglandins Other Lipid Mediat. 2013 Jul-Aug;104-105:2-7. doi: 10.1016/j.prostaglandins.2013.01.002. Epub 2013 Jan 17. Review.

20.

Cytochrome P450 eicosanoids and cerebral vascular function.

Imig JD, Simpkins AN, Renic M, Harder DR.

Expert Rev Mol Med. 2011 Mar 1;13:e7. doi: 10.1017/S1462399411001773. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk